...Some patients who use insulin and EpiPens — the fraction who are served by federally qualified health centers — may benefit from Trump's order, but others could suffer if it results in decreased access for the centers to the 340B drug discount program. Also, the freeze through March 22 does not represent final action on the program, so it's premature to call it a "reversal."...
No comments:
Post a Comment